# EDGAR Filing Document

**Accession Number:** 0000890725
**File Stem:** 0001079973-26-000584
**Filing Date:** 2026-4
**Character Count:** 4262
**Document Hash:** 5bec26b93a8fb8fe8443625cc9768a1d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001079973-26-000584.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001079973-26-000584

**CONFORMED SUBMISSION TYPE**: 1-U

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260302

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GELSTAT CORP
- **CENTRAL INDEX KEY:** 0000890725
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 900075732
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-U
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00600
- **FILM NUMBER:** 26925438

**BUSINESS ADDRESS:**
- **STREET 1:** 333 SE 2ND AVENUE
- **STREET 2:** SUITE 2000
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33131
- **BUSINESS PHONE:** 772-212-1368

**MAIL ADDRESS:**
- **STREET 1:** 333 SE 2ND AVENUE
- **STREET 2:** SUITE 2000
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33131

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DEVELOPED TECHNOLOGY RESOURCE INC
- **DATE OF NAME CHANGE:** 19930309

---

| | |
|:---|:---|
| **UNITED STATES SECURITiES AND EXCHANGE COMMISSION** | **UNITED STATES SECURITiES AND EXCHANGE COMMISSION** |
| **Washington, D.C. 20549** | **Washington, D.C. 20549** |
| **FORM 1-U** | **FORM 1-U** |
| **CURRENT REPORT PURSUANT TO REGULATION A UNDER THE SECURITIES ACT OF 1933** | **CURRENT REPORT PURSUANT TO REGULATION A UNDER THE SECURITIES ACT OF 1933** |
| Date of Report (Date of earliest event reported): April 30, 2026 (March 2, 2026) | Date of Report (Date of earliest event reported): April 30, 2026 (March 2, 2026) |
| **GelStat Corp.** | **GelStat Corp.** |
| (Exact name of issuer as specified in its charter) | (Exact name of issuer as specified in its charter) |
| **Delaware** | **90-0075732** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| **333 SE 2nd Avenue, Suite 2000** | **333 SE 2nd Avenue, Suite 2000** |
| **Miami, Florida 33131** | **Miami, Florida 33131** |
| (Full mailing address of principal executive offices) | (Full mailing address of principal executive offices) |
| **(772) 212-1368** | **(772) 212-1368** |
| (Issuer's telephone number, including area code) | (Issuer's telephone number, including area code) |

---

**CIK: 0000890725**

**Trading Symbol: GSAC**

**OTC Market: OTCIQ / OTCID (Alternative Reporting Standard)**

**Item 9. Other Events**

GELSTAT CORP (the "Company") hereby notifies the Securities and Exchange Commission of its intention to exit ongoing reporting obligations under Regulation A, Tier 2 pursuant to Rule 257(d).

The Company previously qualified an offering under Regulation A, Tier 2 and has been filing ongoing reports on Forms 1-K, 1-Q, and 1-U. The Company has determined that it meets the conditions to suspend its ongoing reporting obligations under Rule 257(d), including:

&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Company has fewer than 300 holders of record of the securities issued in the Regulation A
 offering;

&nbsp;&nbsp;&nbsp;&nbsp;2. The
 Company has terminated or completed the Regulation A offering; and

&nbsp;&nbsp;&nbsp;&nbsp;3. The
 Company is not otherwise required to file reports under Section 13 or 15(d) of the Securities
 Exchange Act of 1934.

Accordingly, the Company intends to transition to the OTC Markets Alternative Reporting Standard (OTCM OTCID) and will no longer file periodic reports with the SEC under Regulation A following the filing of this Form 1-U.

The Company will continue to provide disclosures to the public through the OTC Markets platform consistent with OTC Markets' Alternative Reporting Standard.

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, duly authorized.

**SIGNATURES**

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| April 30, 2026 | **GelStat Corp.** | **GelStat Corp.** |
|  | By: | /s/ Javier Acosta |
|  |  | Javier Acosta |
|  |  | Chief Executive Officer |

---